Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study
Open Access
Abstract
Background: In May 2022, the monkeypox virus outbreak in multiple countries on various continents marked a potential resurgence of the disease as a global health issue. Considering the crucial role of physicians in mitigating the monkeypox outbreak, we sought to evaluate physicians’ knowledge, attitude, concerns, and vaccine acceptance for monkeypox, in the shadow of the COVID-19 pandemic. Methods: A large-scale, cross-sectional survey was conducted among 283 physicians between 20 August–2 September 2022, in Turkey. The participants’ sociodemographic characteristics, knowledge, attitudes, concerns, and vaccine acceptance toward monkeypox infection were collected via a questionnaire. Results: Our study revealed that 32.5% of physicians achieved a good level of knowledge; similarly, 31.4% of the physicians planned to have the monkeypox vaccine. Multivariate binary logistic regression analysis showed that female physicians (p = 0.031) and older people (≥30 vs. p = 0.007). We found that participants from divisions of internal medicine (p = 0.033) who knew about the monkeypox disease during medical school or residency (p = 0.005) and were previously exposed to COVID-19 disease (p = 0.005) were more likely to have a good knowledge score of monkeypox. We also found that physicians with a good knowledge score were more worried about monkeypox compared to COVID-19 (AOR: 2.22; 95% CI:1.13–4.33; p = 0.019). Additionally, those who had information on monkeypox during medical education (AOR = 2.16, 95% CI = 1.10–4.21; p = 0.024) were more likely to receive the smallpox vaccine to prevent monkeypox viral infection when available. Conclusions: The present study pointed out that physicians in Turkey have unsatisfactory levels of knowledge about the emerging monkeypox. This study results can impede attempts to detect and manage cases of monkeypox and should be addressed through appropriate and timely awareness and educational programs, alerts, and seminars. These might serve as the basis for policymakers’ decisions about promoting national monkeypox vaccination strategies and addressing potential vaccine hesitancy and misinformation when needed.Keywords
This publication has 31 references indexed in Scilit:
- Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challengeVaccine, 2020
- Diagnosis of Imported Monkeypox, Israel, 2018Emerging Infectious Diseases, 2019
- Human Monkeypox: Current State of Knowledge and Implications for the FutureTropical Medicine and Infectious Disease, 2016
- Transmission of Atypical Varicella‐Zoster Virus Infections Involving Palm and Sole Manifestations in an Area with Monkeypox EndemicityClinical Infectious Diseases, 2009
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe DiseaseClinical Infectious Diseases, 2005
- The Detection of Monkeypox in Humans in the Western HemisphereNew England Journal of Medicine, 2004
- The Transmission Potential of Monkeypox Virus in Human PopulationsInternational Journal of Epidemiology, 1988
- Human Monkeypox: Clinical Features of 282 PatientsThe Journal of Infectious Diseases, 1987
- A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.1972